Opendata, web and dolomites

M-DrivE TERMINATED

Metabolic Drivers of Epigenetic Modifications: metabolic inducers of histone post-translational modifications in a biological setting

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 M-DrivE project word cloud

Explore the words cloud of the M-DrivE project. It provides you a very rough idea of what is the project "M-DrivE" about.

characterised    coa    places    affording    bio    coenzyme    acetylation    shown    precursor    serum    organism    international    biochemical    acetyl    natural    first    interplay    inducing    storage    backgrounds    illuminate    subsequent    exploited    partnership    synthesis    ppt    dna    combining    advantage    highlighting    proteins    lack    faulty    tolerated    protein    metabolically    sekirnik    endogenous    stable    cell    translational    substrates    previously    recognise    tools    gene    metabolic    metabolomics    epigenetics    post    dr    function    permeable    interactions    sole    appropriate    influence    position    upregulate    synthesising    species    doses    form    diverse    native    units    unexplored    phosphopantetheine    progress    model    genetic    intracellular    route    expression    histone    vehicle    substrate    electrostatically    rapid    efficient    add    implication    disorder    prolific    realise    donor    complementarity    demonstration    induction    enzymes    modification    chemical    therapeutic    bypassing    acylations    expertise    modifications    cellular    epigenetic    acies    acyl    remove    derivatives    probe    rare    demonstrating    enzyme    metabolism    enrichment   

Project "M-DrivE" data sheet

The following table provides information about the project.

Coordinator
ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO 

Organization address
address: TEHNOLOSKI PARK 21
city: LJUBLJANA
postcode: 1000
website: www.aciesbio.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Slovenia [SI]
 Total cost 157˙287 €
 EC max contribution 157˙287 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACIES BIO BIOTEHNOLOSKE RAZISKAVE IN RAZVOJ DOO SI (LJUBLJANA) coordinator 157˙287.00

Map

 Project objective

Post-translational chemical modifications to histone proteins – the storage units of DNA – influence gene expression electrostatically and through specific protein-protein interactions, the study of which is known as epigenetics. Although many enzymes have been identified which add, remove or recognise these modifications, the implication of metabolism in the induction of epigenetic states is a recent development – particularly highlighting acetyl coenzyme A (CoA) as the sole donor for acetylation. Due to the lack of appropriate biochemical tools, this emerging field has not yet been exploited, however Acies Bio’s leading work on the efficient synthesis of 4’ phosphopantetheine (4-PPT), a natural precursor of the prolific substrate CoA, places us in a unique position to realise the novel approach of metabolically inducing epigenetic modifications. In progress towards therapeutic use bypassing faulty metabolism in a rare genetic disorder, we have shown that 4-PPT is cell permeable, serum-stable, tolerated at high doses without side-effects, and can also upregulate histone acetylation. This presents a previously unexplored route to develop 4-PPT as a novel vehicle for the delivery of diverse intracellular acyl-CoA species, and subsequent histone modification. Taking advantage of the interplay between metabolic and epigenetic states, and the complementarity of backgrounds that Acies Bio and Dr Sekirnik can provide through an international partnership combining expertise in both fields, our proposed work would illuminate recently characterised histone acylations. By synthesising novel 4-PPT derivatives, and demonstrating their activity on a cellular and model organism level, we will develop new tools to enable rapid enrichment of rare endogenous modifications to probe their function. This would form the first demonstration of use of native enzyme substrates to affect epigenetic states, affording new European research opportunities in both metabolomics and epigenetics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "M-DRIVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "M-DRIVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NPsVLCD (2019)

Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease

Read More  

GenEl (2020)

General readout electronics for cross-sectoral application in European research infrastructure

Read More  

NaWaTL (2020)

Narrative, Writing, and the Teotihuacan Language: Exploring Language History Through Phylogenetics, Epigraphy and Iconography

Read More